Schneiderman Prelims Vol-I. qxd

LINEAR COMEDONAL LESIONS
Eccrine nevus with comedones 
AD 117:357–359, 1981
Epidermal nevi with scattered open comedones
Linear basal cell nevus with comedones
Linear lichen planopilaris
Nevus comedonicus
Palmar and plantar lesions of porokeratotic eccrine ostial and
dermal duct nevus
Unilateral punctate porokeratosis
LINEAR LESIONS FROM KOEBNER
Behçet’s disease
Bullous pemphigoid
Darier’s disease
Dermatitis herpetiformis
Eruptive xanthomas 
JAAD 33:834–5, 1995
Erythema multiforme
Lichen niditus
Lichen planus
Mastocytosis
Molluscum contagiosum
Pellagra
Pityriasis rubra pilaris
Psoriasis
Pyoderma gangrenosum
Vasculitis
Verruca vulgaris
Vitiligo
LINEAR LESIONS ALONG VEINS
AUTOIMMUNE DISEASES, AND DISEASES
OF IMMUNE DYSFUNCTION
Collagen vascular diseases – linear hyperpigmentation
overlying veins 
JAAD 29:1039–1040, 1993
Lupus erythematosus – supravenous hyperpigmentation
JAAD 43:540–546, 2000
LINEAR LESIONS ALONG VEINS
315
Schneiderman page 300-400.qxd 5/16/2006 6:50 PM Page 315

---

Relapsing polychondritis – superficial thrombophlebitis
Rook p.2042, 1998, Sixth Edition; Medicine 55:193–216, 1976
Rheumatoid arthritis – erythema, papules, and/or
hyperpigmentation 
JAAD 29:1039–1040, 1993
Scleroderma – supravenous erythema, papules, and/or
hyperpigmentation; pigment retention over superficial blood
vessels in area of depigmentation 
JAAD 11:265–268, 1984
CONGENITAL DISORDERS
Sinus pericranii – alopecic red or blue nodule of scalp
with outline of underlying veins within the nodule
JAAD 46:934–941, 2002
DRUGS
Actinomycin and vincristine 
JAAD 43:540–546, 2000
Bromodeoxyuridine – linear supravenous papules and erythema
JAAD 43:540–546, 2000; AD 122:199–200, 1986
Corticosteroids – post-steroid injection atrophy and/or
hypopigmentation along draining lymphatics
Cyclophosphamide 
JAAD 43:540–546, 2000
CHOP therapy 
JAAD 43:540–546, 2000
Docataxel – supravenous hyperpigmentation
BJD 142:1069–1070, 2000
Doxorubicin 
JAAD 43:540–546, 2000; supravenous urticaria
(3%) 
Cancer Treatment Reports 63:2027–2069, 1979; Cancer
Chemotherapy Reports 59:1177–1179, 1975
5-fluorouracil – erythema or pigmentation overlying veins 
JAAD
53:529–530, 2005; JAAD 43:540–546, 2000; JAAD 39:839–842,
1998; AD 129:644–645, 1993; JAAD 25:905, 1991
Fotemustine – pigmentation overlying veins 
JAAD 39:839–842,
1998
Minocycline – supravenous hyperpigmentation of veins
previously treated with sclerotherapy 
JAAD 44:342–347, 2001
Mitomycin – papules 
JAAD 43:540–546, 2000
Polychemotherapy – pigmentation overlying veins
JAAD 39:839–842, 1998
Triazinate – pigmentation overlying veins 
JAAD 39:839–842,
1998
Vinblastine 
JAAD 43:540–546, 2000
Vinorelbine – pigmentation overlying veins 
JAAD 39:839–842,
1998